RFP QuestBeta
ClosedStage · contract

CELL THERAPY CATAPULT LIMITED

The Supply and Implementation of a Warehouse Management System

Software & IT SystemsCPV 48000000 71900000
Value£550k
Deadline15 Feb 2017
Published30 Jan 2017
RegionLondon
Timeline
Published 30 Jan 2017ClosedCloses 15 Feb 2017
Contract value in context
£550ktotal contract value
median £91k
this tender£0£1.1m

This is a large award for Software & IT Systems — above three-quarters of comparable contracts. Based on 30,286 valued Software & IT Systems tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

Cell & Gene Therapy Catapult (CGTC) is part of a world-leading network of technology and innovation centres, established in December 2012 and now with over 100 employees, we believe through science and industry, Our expertise in cell and gene therapies will one day provide better treatments that will help improve patient quality of life whilst building a global industry the UK can be proud of.

Our mission to deliver health and wealth is supported by the UK's enviable academic base.

We strive to be a world leader in cell and gene therapy and support those who wish to convert research into products that have the potential to have direct impact in advanced healthcare.

CGTC is not alone in this ambition.

Regenerative medicine is one of the government's eight great technologies that support UK science strengths and capabilities.

CGTC's offices are located in Guys Hospital in London.

CGTC are building a £55m large-scale GMP Manufacturing Centre to help bring cell and gene therapies to market in the UK and internationally.

It will provide the UK with the manufacturing facilities needed for later-stage cell and gene therapy clinical studies and commercialisation.

The centre benefits from an established supply chain, prime UK location in Stevenage and expert impartial advice from the Cell and Gene Therapy Catapult, enabling the manufacture of therapies to the highest grade, with minimal risk and 100 percent control.

This procurement is for the supply, implementation and support of a Warehouse Management System (WMS) for CGTC.

The WMS solution will cover two sites, primarily the manufacturing centre in Stevenage with a subset of system functionality available for use at CGTC's Guys Hospital location.

CGTC is committed to implementing an WMS system as a priority by November 2017 in time for the opening of the Manufacturing Centre.

Completion of formal GMP system qualification would be required to be completed no later than November 2017 in anticipation of inspection for licensure in December 2017.

The WMS solution will include product inventory, warehousing operations and stock control management as standard functionality along with associated supporting API interfaces.

The potential budget for the WMS system is between £350,000 to £550,000 total excluding VAT for the potential 5 year contract (3 years initially plus two further periods of up to 24 months).

Key requirements

What the supplier must deliver

01

Our expertise in cell and gene therapies

Our expertise in cell and gene therapies will one day provide better treatments that will help improve patient quality of life whilst building a global industry the UK can be proud of.

02

Our mission to deliver health and wealth

Our mission to deliver health and wealth is supported by the UK's enviable academic base.

03

And support those who wish to convert

and support those who wish to convert research into products that have the potential to have direct impact in advanced healthcare.

04

Regenerative medicine is one of the government's

Regenerative medicine is one of the government's eight great technologies that support UK science strengths and capabilities.

05

It will provide the UK with

It will provide the UK with the manufacturing facilities needed for later-stage cell and gene therapy clinical studies and commercialisation.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at CELL THERAPY CATAPULT LIMITED, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
fa9e05b4-7005-4235-a85f-5fb85ed42b28
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
CON-0082B
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Software & IT Systems

Assembling the market network…

CELL THERAPY CATAPULT LIMITED’s tender network

Assembling the network…

Also open now

Similar open tenders

Finance Management Systems

BELIEVE HOUSING LIMITED

Closes 3 Sept 2026IT Services
£1.5mValue

Asset Management System

PROGRESS HOUSING GROUP LIMITED

Closes 21 Jul 2026Software & IT Systems
£350kValue